These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30102783)

  • 21. Modeling radiation pneumonitis of pulmonary stereotactic body radiotherapy: The impact of a local dose-effect relationship for lung perfusion loss.
    Selvaraj J; Lebesque J; Hope A; Guckenberger M; Werner-Wasik M; Peulen H; Giuliani M; Mantel F; Belderbos J; Grills I; Sonke JJ
    Radiother Oncol; 2019 Mar; 132():142-147. PubMed ID: 30825963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal tissue complication probability models for severe acute radiological lung injury after radiotherapy for lung cancer.
    Avanzo M; Trovo M; Furlan C; Barresi L; Linda A; Stancanello J; Andreon L; Minatel E; Bazzocchi M; Trovo MG; Capra E
    Phys Med; 2015 Feb; 31(1):1-8. PubMed ID: 25455442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: A dosimetric pooled analysis of individual patient data.
    Bai H; Wang XF; Xu YH; Zaorsky NG; Wang HH; Niu GM; Li JC; Dong Y; Li JY; Yu L; Chen MF; Lu XT; Yuan ZY; Yang JL; Meng MB
    Radiother Oncol; 2024 Nov; 200():110529. PubMed ID: 39255923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of radiation-induced liver disease using the Lyman NTCP model.
    Dawson LA; Normolle D; Balter JM; McGinn CJ; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):810-21. PubMed ID: 12095546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep learning prediction of post-SBRT liver function changes and NTCP modeling in hepatocellular carcinoma based on DGAE-MRI.
    Wei L; Aryal MP; Cuneo K; Matuszak M; Lawrence TS; Ten Haken RK; Cao Y; Naqa IE
    Med Phys; 2023 Sep; 50(9):5597-5608. PubMed ID: 36988423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal tissue complication probability (NTCP) models of acute urinary toxicity (AUT) following carbon ion radiotherapy (CIRT) for prostate cancer.
    Li Y; Li P; Hsi W; Hong Z; Fu S; Zhang Q
    Radiother Oncol; 2021 Mar; 156():69-79. PubMed ID: 33309999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
    Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
    J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Random forests to predict rectal toxicity following prostate cancer radiation therapy.
    Ospina JD; Zhu J; Chira C; Bossi A; Delobel JB; Beckendorf V; Dubray B; Lagrange JL; Correa JC; Simon A; Acosta O; de Crevoisier R
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1024-1031. PubMed ID: 25035205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
    Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late urinary toxicity modeling after stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
    Kole TP; Tong M; Wu B; Lei S; Obayomi-Davies O; Chen LN; Suy S; Dritschilo A; Yorke E; Collins SP
    Acta Oncol; 2016; 55(1):52-8. PubMed ID: 25972264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
    Grimm J; Vargo JA; Mavroidis P; Moiseenko V; Emami B; Jain S; Caudell JJ; Clump DA; Ling DC; Das S; Moros EG; Vinogradskiy Y; Xue J; Heron DE
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):147-159. PubMed ID: 33583641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments.
    Lee TF; Chao PJ; Wang HY; Hsu HC; Chang P; Chen WC
    BMC Cancer; 2012 Dec; 12():567. PubMed ID: 23206972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of the normal tissue complication probability models and parameters: Head and neck cancers treated with conformal radiotherapy.
    Tajiki S; Joya M; Gharekhani V; Richeson D; Gholami S
    Head Neck; 2023 Dec; 45(12):3146-3156. PubMed ID: 37767820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTCP modeling of subacute/late laryngeal edema scored by fiberoptic examination.
    Rancati T; Fiorino C; Sanguineti G
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):915-23. PubMed ID: 19747783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4π noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity.
    Rwigema JC; Nguyen D; Heron DE; Chen AM; Lee P; Wang PC; Vargo JA; Low DA; Huq MS; Tenn S; Steinberg ML; Kupelian P; Sheng K
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):401-9. PubMed ID: 25482301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.
    Houweling AC; Philippens ME; Dijkema T; Roesink JM; Terhaard CH; Schilstra C; Ten Haken RK; Eisbruch A; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1259-65. PubMed ID: 20005639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
    Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the use of published radiobiological parameters and the evaluation of NTCP models regarding lung pneumonitis in clinical breast radiotherapy.
    Svolos P; Tsougos I; Kyrgias G; Kappas C; Theodorou K
    Australas Phys Eng Sci Med; 2011 Apr; 34(1):69-81. PubMed ID: 21213098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation-induced inferior brachial plexopathy after stereotactic body radiotherapy: Pooled analyses of risks.
    Milano MT; Mavroidis P; Ryckman J; Yorke E; Doucette C; Mahadevan A; Kapitanova I; Spring Kong FM; Marks LB; Grimm J
    Radiother Oncol; 2023 May; 182():109583. PubMed ID: 36842665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.